Clinical Trials on CNV
Total 4911 results
-
CHU de ReimsCompletedMultiple Sclerosis
-
Delta Crystallon BVCompleted
-
BiogenCompletedMultiple SclerosisColombia, Mexico
-
University of ZurichDivision of Infectious Diseases and Hospital EpidemiologyCompleted
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR)Enrolling by invitationSARS-CoV-2 Infection | Post-acute Sequelae of SARS-CoV-2Canada
-
A.O. Ospedale Papa Giovanni XXIIICompletedSevere Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 InfectionItaly
-
Hospital do Rim e HipertensãoNot yet recruiting
-
Daiichi Sankyo, Inc.TerminatedNon-CNS Germ Cell Tumors (Seminomas and Nonseminomas)United States, France, United Kingdom
-
University of Missouri-ColumbiaCompletedSARS-CoV 2 | SARS PneumoniaUnited States
-
Children's National Research InstituteM.D. Anderson Cancer CenterCompleted
-
University Hospital, LimogesTerminatedRenal Transplant Recipient | Immunized Against the CytomegalovirusFrance
-
Hospital Ruber InternacionalZogenix, Inc.RecruitingRefractory Epilepsy | STXBP1 Encephalopathy With Epilepsy | SYNGAP1 Encephalopathy | Inv Dup(15) Encephalopathy | Multifocal or Bilateral Malformations of Cortical Development | Continuous Spike and Waves During Slow SleepSpain
-
Fayoum UniversityCompleted
-
Rennes University HospitalUnknownARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2 | Acute Refractory Heart Failure Related to SARS-CoV 2France
-
Karsten KönigsteinUniversity of Basel; QIAGEN Gaithersburg, IncCompletedAerobic Exercise | Endothelial Function | Middle-aged Adults Sedentary, Elevated CV-risk)Switzerland
-
Innodem NeurosciencesSyneos HealthRecruiting
-
LAPIX Therapeutics Inc.RecruitingMultiple Sclerosis | Autoimmune DiseasesUnited States, Jordan
-
BiogenRecruitingMultiple SclerosisSpain, Ireland, United States, Germany
-
Nottingham University Hospitals NHS TrustJohns Hopkins UniversityNot yet recruitingMultiple Sclerosis
-
University of Colorado, DenverGenentech, Inc.Recruiting
-
S. Andrea HospitalRecruitingMultiple SclerosisItaly
-
Johns Hopkins UniversityCompletedMultiple SclerosisUnited States
-
Queen Mary University of LondonCompleted
-
University of ChicagoTerminated
-
Turku University HospitalActive, not recruiting
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited Kingdom
-
University Hospital, BordeauxBiogenCompletedMultiple SclerosisFrance, Martinique
-
SanofiCompletedMultiple SclerosisUnited States
-
SanofiCompletedMultiple SclerosisUnited States, Canada
-
Centre Hospitalier Universitaire de NiceGenzyme, a Sanofi CompanyCompletedMultiple SclerosisTurkey, France, Switzerland
-
MedicagoCompleted
-
Novartis PharmaceuticalsCompleted
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
GeNeuro Australia PTY LtdCompleted
-
Colorado State UniversityCompletedMultiple SclerosisUnited States
-
BiogenCompletedMultiple SclerosisUnited States
-
University Hospital MuensterUnknown
-
Oregon Health and Science UniversityCompleted
-
Clinique Neuro-OutaouaisCompletedMultiple SclerosisCanada
-
Clinique Neuro-OutaouaisCogState Ltd.CompletedMultiple SclerosisCanada
-
Universitätsklinikum Hamburg-EppendorfUnknown
-
Kessler FoundationUnknown
-
Multiple Sclerosis Center of Northeastern New YorkIcahn School of Medicine at Mount Sinai; BiogenUnknownMultiple SclerosisUnited States
-
BiogenCompleted
-
GlaxoSmithKlineCompleted
-
Virginia SimnadBiogenUnknown
-
University at BuffaloCompleted